AAAAAA

   
Results: 1-22 |
Results: 22

Authors: CHAISSON RE GALLANT JE KERULY JC MOORE RD
Citation: Re. Chaisson et al., IMPACT OF OPPORTUNISTIC DISEASE ON SURVIVAL IN PATIENTS WITH HIV-INFECTION, AIDS, 12(1), 1998, pp. 29-33

Authors: GALLANT JE CHAISSON RE MOORE RD
Citation: Je. Gallant et al., THE EFFECT OF ADJUNCTIVE CORTICOSTEROIDS FOR THE TREATMENT OF PNEUMOCYSTIS-CARINII PNEUMONIA ON MORTALITY AND SUBSEQUENT COMPLICATIONS, Chest, 114(5), 1998, pp. 1258-1263

Authors: PONS V GREENSPAN D LOZADANUR F MCPHAIL L GALLANT JE TUNKEL A JOHNSON CC MCCARTY J PANZER H LEVENSTEIN M BARRANCO A GREEN S
Citation: V. Pons et al., OROPHARYNGEAL CANDIDIASIS IN PATIENTS WITH AIDS - RANDOMIZED COMPARISON OF FLUCONAZOLE VERSUS NYSTATIN ORAL SUSPENSIONS, Clinical infectious diseases, 24(6), 1997, pp. 1204-1207

Authors: MAENZA JR MERZ WG ROMAGNOLI MJ KERULY JC MOORE RD GALLANT JE
Citation: Jr. Maenza et al., INFECTION DUE TO FLUCONAZOLE-RESISTANT CANDIDA IN PATIENTS WITH AIDS - PREVALENCE AND MICROBIOLOGY, Clinical infectious diseases, 24(1), 1997, pp. 28-34

Authors: CHAISSON RE KERULY JC MCAVINUE S GALLANT JE MOORE RD
Citation: Re. Chaisson et al., EFFECTS OF AN INCENTIVE AND EDUCATION-PROGRAM ON RETURN RATES FOR PPDTEST READING IN PATIENTS WITH HIV-INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 11(5), 1996, pp. 455-459

Authors: GALLANT JE KO AH
Citation: Je. Gallant et Ah. Ko, CAVITARY PULMONARY-LESIONS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 22(4), 1996, pp. 671-682

Authors: GALLANT JE ABRAMS JE MCAVINUE SM QUINN TC CHAISSON RE
Citation: Je. Gallant et al., PREVIOUSLY UNRECOGNIZED HIV-INFECTION AMONG HOSPITALIZED-PATIENTS, Infectious diseases in clinical practice, 5(6), 1996, pp. 380-386

Authors: CHEEVER LW CHAISSON RE GALLANT JE
Citation: Lw. Cheever et al., PROPHYLAXIS AGAINST OPPORTUNISTIC INFECTIONS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, Western journal of medicine, 165(1-2), 1996, pp. 67-73

Authors: GALLANT JE MOORE RD CHAISSON RE
Citation: Je. Gallant et al., ACYCLOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUS PATIENTS - REPLY, The Journal of infectious diseases, 173(2), 1996, pp. 505-507

Authors: MAENZA JR KERULY JC MOORE RD CHAISSON RE MERZ WG GALLANT JE
Citation: Jr. Maenza et al., RISK-FACTORS FOR FLUCONAZOLE-RESISTANT CANDIDIASIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, The Journal of infectious diseases, 173(1), 1996, pp. 219-225

Authors: GALLANT JE BARTLETT JG CHAISSON RE
Citation: Je. Gallant et al., THE EFFECT OF PROPHYLAXIS ON THE OUTCOME OF HIV-ASSOCIATED PNEUMOCYSTIS-CARINII PNEUMONIA, Chest, 109(2), 1996, pp. 587-587

Authors: KO AH THOMAS DL GALLANT JE
Citation: Ah. Ko et al., NON-HODGKINS-LYMPHOMA AND KAPOSIS-SARCOMA CAUSING CAVITARY LUNG LESIONS IN A PATIENT WITH AIDS - AN HIV-ASSOCIATED COLLISION TUMOR, AIDS, 9(10), 1995, pp. 1195-1197

Authors: GALLANT JE MOORE RD KERULY J RICHMAN DD CHAISSON RE BARTLETT J MCAVINUE S BRYSON Y COHEN H FISCHL M BOLIN T KESSLER H BURROUGH Y MILDVAN D FOX A RICHMAN D FREEMAN B SIMON G GRABOWY KW CHERNOFF D DUFF P THOMPSON S BARRETT K AWE R CHAPMAN R LEONARD S TURNER P HAWKINS M MURRAY H BOWERS J LANE C TILSON H ANDREWS E SMILEY L
Citation: Je. Gallant et al., LACK OF ASSOCIATION BETWEEN ACYCLOVIR USE AND SURVIVAL IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE, The Journal of infectious diseases, 172(2), 1995, pp. 346-352

Authors: GALLANT JE MCAVINUE SM MOORE RD BARTLETT JG STANTON DL CHAISSON RE
Citation: Je. Gallant et al., THE IMPACT OF PROPHYLAXIS ON OUTCOME AND RESOURCE UTILIZATION IN PNEUMOCYSTIS-CARINII PNEUMONIA, Chest, 107(4), 1995, pp. 1018-1023

Authors: GALLANT JE MOORE RD CHAISSON RE
Citation: Je. Gallant et al., PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS - RESPONSE, Annals of internal medicine, 122(9), 1995, pp. 731-731

Authors: GALLANT JE ALWOOD K CHAISSON RE
Citation: Je. Gallant et al., OSTEOMYELITIS DUE TO MYCOBACTERIUM-KANSASII AND MYCOBACTERIUM-AVIUM COMPLEX IN AN HIV-INFECTED PATIENT, Infectious diseases in clinical practice, 3(4), 1994, pp. 297-299

Authors: GALLANT JE MOORE RD RICHMAN DD KERULY J CHAISSON RE BARTLETT J MCAVINUE S BRYSON Y COHEN H FISCHL M BOLIN T BURROUGH Y MILDVAN D FOX A RICHMAN D FREEMAN B SIMON G GRABOWY KW CHERNOFF D DUFF P THOMPSON S BARRETT K AWE R LEONARD S TURNER P HAWKINS M MURRAY H BOWERS J TILSON H SMILEY L
Citation: Je. Gallant et al., RISK-FACTORS FOR KAPOSIS-SARCOMA IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE TREATED WITH ZIDOVUDINE, Archives of internal medicine, 154(5), 1994, pp. 566-572

Authors: GALLANT JE MOORE RD CHAISSON RE
Citation: Je. Gallant et al., PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HIV-INFECTION, Annals of internal medicine, 120(11), 1994, pp. 932-944

Authors: GALLANT JE
Citation: Je. Gallant, PRIMARY-CARE AND PUBLIC-HEALTH - COMMENTARY, Infectious diseases in clinical practice, 2(6), 1993, pp. 426-428

Authors: CHAISSON RE STANTON DL GALLANT JE RUCKER S BARTLETT JG MOORE RD
Citation: Re. Chaisson et al., IMPACT OF THE 1993 REVISION OF THE AIDS CASE-DEFINITION ON THE PREVALENCE OF AIDS IN A CLINICAL SETTING, AIDS, 7(6), 1993, pp. 857-862

Authors: GALLANT JE ELDRED LJ LESLIE JM CHAISSON RE QUINN TC
Citation: Je. Gallant et al., IMPACT OF THE 1993 REVISION OF THE CDC CASE-DEFINITION ON THE PERFORMANCE OF THE WHO AND PAHO CLINICAL CASE DEFINITIONS FOR AIDS, AIDS, 7(10), 1993, pp. 1396-1397

Authors: GALLANT JE CHAISSON RE KERULY J MOORE RD
Citation: Je. Gallant et al., FACTORS ASSOCIATED WITH INCREASED RISK OF ACQUIRING CYTOMEGALOVIRUS DISEASE IN AIDS PATIENTS - REPLY, The Journal of infectious diseases, 168(4), 1993, pp. 1072-1072
Risultati: 1-22 |